CD133+ and CD24+CD44+ESA+ cells are considered pancreatic cancer stem cells, and the proliferation of CD133+ but not CD24+CD44+ESA+ cells was selectively inhibited by low concentrations of metformin. This evidence concerns the gene PROM1 and familial pancreatic carcinoma.